John B. Porter

Long-term prognostic value of serial measurement of ventricular function in the management of homozygous beta-thalassemia.

Bernard A. Davis, Caoimhe OSullivan, Joseph Eliahoo, 2000 .

Secondary hemochromatosis in Bthalassemia and sickle cell disease

John B. Porter, E Vichinsky, Paul Harmatz, 2002 .

Full floating point vector processing unit.

John B. Porter, David W. Altmann, Bruno A. Mattedi, 1984 .

Haemostatic regulation in the haemoglobinopathies

John B. Porter, Ij Mackie, Sj Machin, 1997 .

Myocardial T2* in Patients with Cardiac Failure Secondary to Iron Overload.

John B. Porter, Dudley J. Pennell, Mark A. Tanner, 2005 .

A Risk-Benefit Assessment of Iron-Chelation Therapy

John B. Porter, J. Porter, 1997, Drug safety.